Results 31 to 40 of about 49,999 (280)
Emotions and scope effects in the monetary valuation of health [PDF]
, 2018 JEL classifications: H41 H51 I11 I18 I31This study presents evidence on the role of emotions in the monetary evaluation of health technologies, namely, drug-eluting stents (DES) in our case.
Araña, Jorge +3 more
core +1 more source
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
The Egyptian Heart Journal, 2012 Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry +2 more
doaj +1 more source
Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]
, 2012 Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A +7 more
core +2 more sources
Comportamiento mecánico ante la sobrexpansión de stents de cromo-cobalto comparados con stents de acero inoxidable, implantados en la aorta abdominal de conejos hipercolesterolémicos [PDF]
, 2018 Introducción: La fisiopatología de la disfunción diastólica del ventrículo izquierdo incluye alteraciones de la relajación ventricular, rigidez elástica pasiva o una combinación de ambos mecanismos.
Berrocal, Daniel +5 more
core +1 more source
Bioactive Materials, 2023 Vein grafts are widely used for coronary artery bypass grafting and hemodialysis access, but restenosis remains the ''Achilles' heel'' of these treatments.
Tianshu Chu +7 more
doaj +1 more source
Future of smart cardiovascular implants [PDF]
, 2018 Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav +2 more
core +1 more source
In-Stent Ulceration: An Unusual Pathology
Case Reports in Cardiology, 2014 In-stent restenosis occurs in 10–60% of cases undergoing interventional therapy. Many mechanisms explain the reason for in-stent restenosis, but restenosis due to an ulcerated plaque is very rare and has not been well reported in the literature.
Jagadeesh Kumar Kalavakunta +2 more
doaj +1 more source
Российский кардиологический журнал, 2019 Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames +3 more
doaj +1 more source
Dealing with in-stent restenosis [PDF]
Heart, 1998 Stents have been shown to reduce the incidence of restenosis; however, they are not a cure. In two trials the angiographic restenosis rate was reported to be between 20% and 30% (in the Benestent II trial the unpublished quoted restenosis rate was 15%). These trials were based on stenting short, de novo lesions, in native coronary arteries.
A H, Gershlick, J, Baron
openaire +2 more sources
Clinical evaluation of radioactive stents [PDF]
, 2001 Restenosis, the major problem after stent implantation, is caused by in-stent neointimal hyperplasia. A number of metbods and techniques have been studied during the last ten years to address tbis issue, but in-stent restenosis has remained at a rate of ...
Wardeh, A.J. (Alexander)
core +9 more sources